Cargando…
The Antitumor Activity of the Novel Compound Jesridonin on Human Esophageal Carcinoma Cells
Jesridonin, a small molecule obtained through the structural modification of Oridonin, has extensive antitumor activity. In this study, we evaluated both its in vitro activity in the cancer cell line EC109 and its in vivo effect on tumor xenografts in nude mice. Apoptosis induced by Jesridonin was d...
Autores principales: | Wang, Cong, Jiang, Liping, Wang, Saiqi, Shi, Hongge, Wang, Junwei, Wang, Ran, Li, Yongmei, Dou, Yinhui, Liu, Ying, Hou, Guiqin, Ke, Yu, Liu, Hongmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477902/ https://www.ncbi.nlm.nih.gov/pubmed/26103161 http://dx.doi.org/10.1371/journal.pone.0130284 |
Ejemplares similares
-
Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
por: Wang, Cong, et al.
Publicado: (2017) -
Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A
por: Zhang, Man, et al.
Publicado: (2022) -
Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
por: Hou, Guiqin, et al.
Publicado: (2014) -
Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer
por: Liu, Ying, et al.
Publicado: (2021) -
Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma
por: Lu, Zhaoming, et al.
Publicado: (2016)